title: Imatinib for the treatment of rheumatic diseases.
authors: Division of Immunology and Rheumatology at Stanford University School of Medicine, Stanford, USA.
authors: Ricardo T
authors: RT
authors: Paniagua
authors: William H
authors: WH
authors: Robinson
mesh_terms: D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy; D001549:Benzamides; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000068877:Imatinib Mesylate; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate